MENU
VRNA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Verona Pharma (VRNA) Earnings Date & Reports

A.I. Advisor
published Earnings

VRNA is expected to report earnings to fall 38.18% to -6 cents per share on November 04

Verona Pharma VRNA Stock Earnings Reports
Q3'24
Est.
$-0.07
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.01
Q3'23
Beat
by $0.01
The last earnings report on August 08 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 397.04K shares outstanding, the current market capitalization sits at 2.34B.
View a ticker or compare two or three
VRNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com